Drug:
Reaction: ERYTHEMA
20260101 - 20261231
No. 1001 - 1100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1001 | 26810257 |
EU |
66 | 2 |
Erythema, Eczema, |
||||
IBRUTINIB, CALCIFEDIOL, |
||||
| 1002 | 26810365 |
US |
68 | 1 |
Vision blurred, Erythema, Dry eye, |
||||
DUPILUMAB, |
||||
| 1003 | 26810722 |
US |
40 | 1 |
Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 1004 | 26810837 |
EU |
39 | 2 |
Shrinking lung syndrome, Asthma, Paraplegia, Erythema, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TACROLIMUS, HYDROXYCHLOROQUINE, FOLIC ACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE, IVABRADINE, |
||||
| 1005 | 26811002 |
US |
31 | |
Pruritus, Erythema, Nausea, |
||||
EPTINEZUMAB-JJMR, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FERROUS SULFATE, MONTELUKAST SODIUM, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, UBROGEPANT, CETIRIZINE HYDROCHLORIDE, NORETHINDRONE, RIMEGEPANT SULFATE, ARIPIPRAZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MIRTAZAPINE, FUROSEMIDE, |
||||
| 1006 | 26811120 |
US |
16 | 1 |
Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 1007 | 26811135 |
US |
24 | 2 |
Dermatitis atopic, Scar, Dry skin, Skin fissures, Erythema, Skin swelling, Skin texture abnormal, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1008 | 26811646 |
36 | 2 | |
Erythema, Pruritus, Off label use, |
||||
IRON SUCROSE, |
||||
| 1009 | 26811685 |
US |
1 | |
Rash, Dermatitis atopic, Pruritus, Skin burning sensation, Erythema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1010 | 26811740 |
US |
27 | 2 |
Skin irritation, Erythema, Pruritus, |
||||
TRALOKINUMAB-LDRM, |
||||
| 1011 | 26811808 |
EU |
39 | 2 |
Paraplegia, Shrinking lung syndrome, Asthma, Erythema, |
||||
DEXAMETHASONE SODIUM PHOSPHATE, PIROXICAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, OXYCODONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, HYDROXYCHLOROQUINE SULFATE, TIZANIDINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, FOLIC ACID, |
||||
| 1012 | 26811857 |
US |
81 | 2 |
Erythema, Pain in extremity, |
||||
EVOLOCUMAB, TREPROSTINIL, VITAMIN C, MAGNESIUM, PREDNISONE, OXYGEN, 0XYGEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, TORSEMIDE, IRON SUCROSE, PRIMIDONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1013 | 26811905 |
QA |
47 | 2 |
Angioedema, Erythema, Palpitations, Wheezing, Pyrexia, Headache, Fatigue, Disturbance in attention, Sleep disorder, Insomnia, Migraine, Pain, Pruritus, Urticaria, |
||||
OMALIZUMAB, |
||||
| 1014 | 26812085 |
JP |
2 | |
Interstitial lung disease, Decubitus ulcer, Erythema, |
||||
SARILUMAB, |
||||
| 1015 | 26812545 |
US |
6 | 1 |
Erythema, Respiratory tract infection, Sneezing, Secretion discharge, Cough, |
||||
DUPILUMAB, DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, CETIRIZINE HCL, CETIRIZINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, EPINEPHRINE, ADRENALINUM, FAMOTIDINE, FLUTICASONE PROPIONATE, FLUTICASONE FUROATE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, OLOPATADINE HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE OPHTHALMIC, OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1016 | 26812832 |
JP |
29 | 2 |
Drug reaction with eosinophilia and systemic symptoms, Guillain-Barre syndrome, Fulminant type 1 diabetes mellitus, Pyrexia, Erythema, Liver disorder, Rash, Leukoderma, Alopecia, Product use in unapproved indication, Off label use, |
||||
LAMOTRIGINE, |
||||
| 1017 | 26812963 |
US |
34 | 1 |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, FLUOXETINE HYDROCHLORIDE, TAPINAROF, LISDEXAMFETAMINE DIMESYLATE, |
||||
| 1018 | 26816173 |
86 | 2 | |
Sinusitis, Hip surgery, Hip fracture, Erythema, |
||||
ETANERCEPT, |
||||
| 1019 | 26816395 |
49 | 1 | |
Dermatitis atopic, Swelling, Pruritus, Erythema, |
||||
TRALOKINUMAB-LDRM, |
||||
| 1020 | 26803862 |
CN |
69 | 1 |
Nausea, Vomiting, Decreased appetite, Asthenia, Oral herpes, Lip swelling, Lip pain, Erythema, White blood cell count decreased, Poor quality sleep, Listless, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 1021 | 26804087 |
US |
68 | |
Neurodermatitis, Erythema, Pain of skin, Drug ineffective, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1022 | 26804108 |
2 | ||
Asthenia, Dizziness, Swelling face, Erythema, Weight increased, |
||||
DATOPOTAMAB DERUXTECAN, |
||||
| 1023 | 26804206 |
US |
50 | 2 |
Dizziness, Erythema, Inappropriate schedule of product administration, |
||||
| 1024 | 26804686 |
EG |
||
Hypoaesthesia, Swelling, Agitation, Hypotension, Erythema, |
||||
CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 1025 | 26805717 |
EU |
72 | 1 |
Oculogyric crisis, Musculoskeletal stiffness, Peripheral swelling, Condition aggravated, Bruxism, Abnormal behaviour, On and off phenomenon, Cough, Malaise, Skin irritation, Dyskinesia, Pruritus, Erythema, Nausea, Vomiting, Therapeutic product effect decreased, Treatment noncompliance, Wrong technique in product usage process, Wrong technique in device usage process, Product use issue, Incorrect dose administered by device, Product communication issue, Device occlusion, Product residue present, Product physical issue, Device issue, |
||||
RIVASTIGMINE, LEVODOPA, LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE, SAFINAMIDE MESYLATE, SAFINAMIDE MESYLATE, OPICAPONE, ROSUVASTATIN, ALLOPURINOL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RIVASTIGMINE, |
||||
| 1026 | 26806151 |
US |
79 | 2 |
Dizziness, Pruritus, Pain, Erythema, Somnolence, Diarrhoea, Injection site pruritus, Injection site erythema, |
||||
SARILUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, NINTEDANIB, |
||||
| 1027 | 26806168 |
US |
42 | 1 |
Insomnia, Hyperaesthesia teeth, Erythema, Dry skin, |
||||
DUPILUMAB, |
||||
| 1028 | 26806292 |
US |
58 | 2 |
Anaphylactic reaction, Combined immunodeficiency, Dermatomyositis, Immunodeficiency common variable, Cataract, Off label use, Rash, Rash pruritic, Fatigue, Hypersomnia, Head discomfort, Crying, Insomnia, Fall, Joint dislocation, Blood immunoglobulin G decreased, Blood immunoglobulin M decreased, Blood immunoglobulin A decreased, T-lymphocyte count decreased, Bone pain, Headache, Erythema, Pain in extremity, Ankle fracture, Arthralgia, Joint swelling, Visual impairment, Allergy to immunoglobulin therapy, Contusion, Injection site pain, Injection site reaction, Injection site discolouration, Injection site erythema, Hypoaesthesia oral, |
||||
ASFOTASE ALFA, |
||||
| 1029 | 26806648 |
CN |
48 | 2 |
Rhabdomyolysis, Erythema, |
||||
ATORVASTATIN CALCIUM, |
||||
| 1030 | 26806651 |
EU |
23 | |
Pruritus, Erythema, Rhinorrhoea, Lacrimation increased, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 1031 | 26806801 |
US |
57 | 2 |
Eye irritation, Erythema, Rash, |
||||
ACOLTREMON, FREMANEZUMAB-VFRM, BUPROPION HYDROCHLORIDE, TIZANIDINE, PREGABALIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, HYDROXYCHLOROQUINE, BELIMUMAB, |
||||
| 1032 | 26806845 |
CN |
80 | 1 |
Pruritus, Erythema, Swelling, Condition aggravated, Pustule, Skin erosion, Scratch, Scab, Skin temperature increased, |
||||
CRISABOROLE, |
||||
| 1033 | 26806859 |
CN |
14 | 2 |
Rash, Erythema, Swelling face, Rash erythematous, Rash pruritic, Drug hypersensitivity, |
||||
CYTARABINE, |
||||
| 1034 | 26806867 |
CA |
69 | 1 |
Erythema, Pruritus, |
||||
RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 1035 | 26806870 |
CA |
70 | 1 |
Erythema, Pruritus, Urticaria, |
||||
RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 1036 | 26806874 |
CA |
59 | 2 |
Acne, Anti-GAD antibody, Colitis, Condition aggravated, Cough, Dental caries, Drug hypersensitivity, Dysphagia, Erythema, Fatigue, Feeling hot, Headache, Herpes zoster, Hot flush, Hyperaesthesia teeth, Illness, Malaise, Nasal discomfort, Nasal pruritus, Nasopharyngitis, Nausea, Neurological symptom, Oedema peripheral, Oropharyngeal discomfort, Pain in jaw, Palpitations, Paraesthesia, Peripheral swelling, Pharyngeal paraesthesia, Pruritus, Pulpitis dental, Rash macular, Rash pruritic, Skin plaque, Sleep disorder, Swelling face, Symptom recurrence, Tachycardia, Throat irritation, Tooth infection, Toothache, Vaginal infection, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE, |
||||
| 1037 | 26806911 |
EU |
64 | 1 |
Dyspnoea, Chest discomfort, Erythema, Pruritus, |
||||
OXALIPLATIN, |
||||
| 1038 | 26806978 |
US |
15 | 1 |
Eczema, Pruritus, Inflammation, Erythema, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1039 | 26807019 |
US |
40 | 2 |
Swelling, Upper-airway cough syndrome, Oedema, Nasal turbinate hypertrophy, Tongue geographic, Asthma, Blood pressure abnormal, Dysphonia, Dyspnoea, Atopy, Chest discomfort, Cough, Erythema, Nasal turbinate hypertrophy, Fatigue, |
||||
ERENUMAB-AOOE, TEZEPELUMAB-EKKO, ESZOPICLONE, OMALIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MAGNESIUM, PROPRANOLOL HYDROCHLORIDE, ERGOCALCIFEROL, FREMANEZUMAB-VFRM, ALBUTEROL SULFATE, CIMETIDINE, CYCLOBENZAPRINE, UBROGEPANT, EPINEPHRINE, ADRENALINUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 1040 | 26807853 |
US |
1 | |
Skin exfoliation, Skin exfoliation, Erythema, Skin atrophy, Inflammation, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 1041 | 26807942 |
42 | 2 | |
Liver function test increased, Dyspepsia, Gastritis, Erythema, Epistaxis, Dyspepsia, Flatulence, Oropharyngeal pain, Disorientation, Feeding disorder, Fatigue, Somnolence, Stoma creation, Diarrhoea, Abdominal pain, Nausea, Vomiting, Toxicity to various agents, Dyspepsia, Nausea, Vomiting, Feeding disorder, Weight decreased, Alopecia, Pain of skin, Oropharyngeal discomfort, Gingival pain, Gingival bleeding, Epistaxis, Off label use, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 1042 | 26807973 |
EU |
43 | 2 |
Erythema, Skin burning sensation, |
||||
NILOTINIB, |
||||
| 1043 | 26807980 |
US |
2 | |
Drug hypersensitivity, Urticaria, Pruritus, Rash erythematous, Erythema, |
||||
OFATUMUMAB, OFATUMUMAB, FAMOTIDINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 1044 | 26808129 |
EU |
11 | 1 |
Drug ineffective, Erythema, Skin striae, Telangiectasia, Skin atrophy, Obesity, |
||||
METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, DAPSONE GEL, 5%, DAPSONE, DASPONE, DAPSONE GEL, 5%, DAPSONE, DASPONE, |
||||
| 1045 | 26808172 |
US |
23 | |
Dermatitis atopic, Erythema, Skin warm, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1046 | 26808177 |
US |
72 | 2 |
Injection site pruritus, Injection site erythema, Erythema, |
||||
PENTAMIDINE ISETHIONATE, |
||||
| 1047 | 26808179 |
US |
71 | 1 |
Injection site pruritus, Injection site erythema, Erythema, |
||||
PENTAMIDINE ISETHIONATE, PENTAMIDINE ISETHIONATE, |
||||
| 1048 | 26808198 |
CN |
1 | |
Peripheral nerve injury, Hypoaesthesia, Erythema, |
||||
DURVALUMAB, |
||||
| 1049 | 26808265 |
US |
31 | 1 |
Urticaria, Erythema, |
||||
IOHEXOL, IOHEXOL, |
||||
| 1050 | 26808297 |
EU |
39 | 2 |
Paraplegia, Shrinking lung syndrome, Asthma, Erythema, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PIROXICAM, OXYCODONE, IVABRADINE, HYDROXYCHLOROQUINE, TIZANIDINE HYDROCHLORIDE, TACROLIMUS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOLIC ACID, |
||||
| 1051 | 26808389 |
US |
28 | 2 |
Urticaria, Erythema, |
||||
IOHEXOL, IOHEXOL, |
||||
| 1052 | 26808410 |
US |
14 | 2 |
Dry skin, Erythema, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1053 | 26808875 |
US |
12 | 2 |
Skin haemorrhage, Scratch, Erythema, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1054 | 26810797 |
79 | 1 | |
Erythema, Nausea, Blood pressure decreased, |
||||
DONANEMAB-AZBT, |
||||
| 1055 | 26798520 |
US |
73 | 1 |
Pruritus, Rash macular, Erythema, Sleep disorder, |
||||
LEBRIKIZUMAB-LBKZ, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, AMLODIPINE BESYLATE, CLONIDINE HYDROCHLORIDE, LISINOPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 1056 | 26798617 |
AU |
||
Erythema, Swelling, Thrombophlebitis, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 1057 | 26798754 |
52 | ||
Swelling, Candida infection, Erythema, |
||||
BIMEKIZUMAB, |
||||
| 1058 | 26798932 |
US |
2 | |
Skin swelling, Erythema, Eczema, |
||||
DUPILUMAB, |
||||
| 1059 | 26798954 |
CA |
54 | 2 |
Peripheral coldness, Swelling face, Hyperventilation, Diarrhoea, Chest pain, Erythema, Fatigue, Myocardial infarction, Nausea, Paraesthesia, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DAPAGLIFLOZIN, INSULIN HUMAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PANTOPRAZOLE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN, ORAL SEMAGLUTIDE, SULFASALAZINE, |
||||
| 1060 | 26799130 |
US |
36 | 2 |
Fatigue, Erythema, Chest discomfort, Hyperhidrosis, |
||||
FERRIC DERISOMALTOSE, |
||||
| 1061 | 26799701 |
EU |
3 | 1 |
Pneumonia, Pyrexia, Cough, Oropharyngeal erythema, Erythema, |
||||
| 1062 | 26799992 |
TR |
37 | 2 |
Dyspnoea, Erythema, Swelling face, Tachycardia, Nausea, Vomiting, |
||||
PERTUZUMAB, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 1063 | 26800001 |
US |
16 | 2 |
Erythema, Eczema, |
||||
DUPILUMAB, |
||||
| 1064 | 26800061 |
US |
2 | |
Contusion, Erythema, Headache, Product use in unapproved indication, |
||||
DUPILUMAB, REMIBRUTINIB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AZELASTINE HYDROCHLORIDE, AZELASTINE, AMLODIPINE BESYLATE AND VALSARTAN, HYDROCHLOROTHIAZIDE, IRON, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, |
||||
| 1065 | 26800124 |
US |
45 | 2 |
Swelling face, Erythema, Feeling hot, Lymphadenopathy, Influenza, |
||||
ASFOTASE ALFA, ASFOTASE ALFA, |
||||
| 1066 | 26800246 |
EU |
60 | 1 |
Wound necrosis, Muscle necrosis, Wound, Pain in extremity, Administration site extravasation, Infusion site pain, Infusion site erythema, Infusion site vesicles, Erythema, |
||||
DOXORUBICIN, |
||||
| 1067 | 26800460 |
CA |
23 | 1 |
Arthralgia, Decreased appetite, Diarrhoea, Drug hypersensitivity, Erythema, Rash, Vomiting, Eye discharge, Stevens-Johnson syndrome, Tenderness, |
||||
PENICILLAMINE, ERGOCALCIFEROL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 1068 | 26800466 |
US |
68 | 1 |
Transurethral prostatectomy, Procedural haemorrhage, Procedural pain, Urinary retention, Chronic inflammatory demyelinating polyradiculoneuropathy, Erythema, Muscular weakness, Coordination abnormal, Loss of personal independence in daily activities, Depression, Dysuria, Rash macular, Injection site pruritus, Injection site pain, Injection site pain, Drug ineffective, |
||||
EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT), |
||||
| 1069 | 26800604 |
CA |
30 | 2 |
Cheilitis, Cough, Erythema, Pruritus, Rash erythematous, Throat irritation, Off label use, |
||||
RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 1070 | 26800627 |
EU |
86 | 1 |
Hepatitis cholestatic, Eosinophilia, Pyrexia, C-reactive protein increased, Erythema, |
||||
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 1071 | 26800719 |
US |
75 | 2 |
Cough, Erythema, |
||||
VIBEGRON, LOSARTAN, SIMVASTATIN, RIVAROXABAN, DOCUSATE SODIUM, |
||||
| 1072 | 26800814 |
US |
17 | 2 |
Pruritus, Dermatitis atopic, Erythema, Skin exfoliation, Stress, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1073 | 26801114 |
|||
Erythema, Rash, Pruritus, Skin burning sensation, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 1074 | 26801245 |
US |
17 | 2 |
Dry skin, Erythema, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 1075 | 26801257 |
CA |
2 | |
Asthma, Cushing^s syndrome, Skin swelling, Weight increased, Eczema, Pruritus, Erythema, Skin irritation, Pain of skin, Hyperhidrosis, Scratch, Product use in unapproved indication, Sleep disorder due to a general medical condition, Emotional distress, Dry skin, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, PREDNISONE, |
||||
| 1076 | 26801436 |
JP |
76 | 1 |
Cytokine release syndrome, Hepatitis B reactivation, Hypogammaglobulinaemia, Eosinophilia, Erythema, |
||||
TECLISTAMAB-CQYV, TECLISTAMAB-CQYV, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ACYCLOVIR, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 1077 | 26801554 |
78 | 2 | |
Tremor, Agitation, Insomnia, Swelling face, Erythema, Blood pressure increased, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 1078 | 26801766 |
CN |
71 | 1 |
Drug eruption, Erythema, Blister, Pruritus, Axillary pain, Skin lesion, |
||||
ISATUXIMAB, ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB, |
||||
| 1079 | 26801920 |
CN |
57 | 1 |
Erythema, Papule, Dermatitis allergic, Pyrexia, |
||||
CYTARABINE, CYTARABINE, CYTARABINE, |
||||
| 1080 | 26801921 |
EU |
73 | 1 |
Oropharyngeal pain, Throat irritation, Oropharyngeal erythema, Dysphagia, Salivary hypersecretion, Erythema, Nasopharyngitis, Accidental overdose, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, HYDROCORTISONE, |
||||
| 1081 | 26801927 |
JP |
61 | 2 |
Immune effector cell-associated neurotoxicity syndrome, Pneumonia cytomegaloviral, Cytomegalovirus infection reactivation, Erythema, |
||||
ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, |
||||
| 1082 | 26802112 |
42 | 2 | |
Rash, Erythema, Contusion, |
||||
TIRZEPATIDE, |
||||
| 1083 | 26802140 |
US |
51 | 2 |
Sunburn, Skin exfoliation, Eyelids pruritus, Dermatitis atopic, Erythema, Pruritus, Skin swelling, Dry skin, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, OCTOCRYLENE, AVOBENZONE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MAGNESIUM, PROGESTERONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ROFLUMILAST, CETIRIZINE HYDROCHLORIDE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MAGNESIUM, PROGESTERONE, CETIRIZINE HYDROCHLORIDE, ROFLUMILAST, |
||||
| 1084 | 26802260 |
CN |
75 | 2 |
Rash, Erythema, Papule, Pruritus, |
||||
CARBAMAZEPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ALPRAZOLAM, |
||||
| 1085 | 26802522 |
US |
2 | |
Drug ineffective, Erythema, Ocular hyperaemia, |
||||
BRINZOLAMIDE/BRIMONIDINE TARTRATE, |
||||
| 1086 | 26802743 |
CN |
49 | 2 |
Drug eruption, Erythema, Pruritus, Generalised oedema, |
||||
RIBOCICLIB, |
||||
| 1087 | 26802769 |
CN |
71 | 1 |
Pruritus, Vomiting, Hyperhidrosis, Erythema, Nausea, |
||||
FRUQUINTINIB, |
||||
| 1088 | 26802776 |
US |
36 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
| 1089 | 26803029 |
EU |
59 | 1 |
Anaphylactic shock, Hypotension, Erythema, |
||||
PROPOFOL, ROPIVACAINE HYDROCHLORIDE, CEFAZOLIN SODIUM, CEFAZOLIN, ROCURONIUM BROMIDE, FENTANYL CITRATE, |
||||
| 1090 | 26803090 |
57 | ||
Erythema, Injection site irritation, |
||||
BIMEKIZUMAB, |
||||
| 1091 | 26803104 |
38 | 2 | |
Erythema, Urticaria, Peripheral swelling, |
||||
IRON SUCROSE, IRON SUCROSE, |
||||
| 1092 | 26803358 |
US |
1 | |
Infusion related reaction, Flushing, Erythema, Rash, |
||||
ELOSULFASE ALFA, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, EPINEPHRINE, ADRENALINUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METOPROLOL TARTRATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE SODIUM SUCCINATE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 1093 | 26803445 |
US |
25 | 1 |
Eczema, Dry skin, Erythema, Dermatitis, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1094 | 26803596 |
EG |
43 | 1 |
Haematotoxicity, General physical health deterioration, Pruritus, Inflammation, Erythema, Skin burning sensation, Product storage error, Arthritis, Erythema, Skin reaction, Hypersensitivity, Facial pain, Inflammation, Erythema, Pruritus, Burning sensation, Erythema, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 1095 | 26793786 |
US |
57 | 2 |
Eye irritation, Rash, Erythema, |
||||
FREMANEZUMAB-VFRM, ACOLTREMON, BELIMUMAB, BUPROPION HYDROCHLORIDE, TIZANIDINE, PREGABALIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, HYDROXYCHLOROQUINE, |
||||
| 1096 | 26793827 |
CN |
87 | 2 |
Aspartate aminotransferase increased, Alanine aminotransferase increased, Rash, Hepatic function abnormal, Erythema, Pruritus, Drug hypersensitivity, |
||||
| 1097 | 26793871 |
US |
76 | 2 |
Cough, Wheezing, Swelling face, Pain, Swelling, Hypoaesthesia, Arthritis, Injection site warmth, Lichenification, Product use complaint, Erythema, Pruritus, Injection site reaction, Injection site pain, Injection site erythema, Injection site bruising, |
||||
DUPILUMAB, DUPILUMAB, ORAL SEMAGLUTIDE, ALBUTEROL SULFATE, FEXOFENADINE HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AZELASTINE HYDROCHLORIDE, AZELASTINE, BIOTIN, DICYCLOMINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GABAPENTIN, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MONTELUKAST SODIUM, MONTELUKAST, EPINEPHRINE, SPIRONOLACTONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 1098 | 26793884 |
PR |
11 | 2 |
Blister, Rash, Pruritus, Swelling face, Erythema, |
||||
DUPILUMAB, |
||||
| 1099 | 26794137 |
US |
1 | |
Swelling face, Erythema, |
||||
GUSELKUMAB, |
||||
| 1100 | 26794221 |
RS |
2 | |
Erythema, Pruritus, Vision blurred, General physical health deterioration, Communication disorder, Metastases to central nervous system, |
||||
ATEZOLIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
